GA
GSK icon

GFS Advisors’s GSK GSK Stock Holding History

GFS Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,420
Closed -$458K – 141
2022
Q2 		$458K Sell
8,420
-528
-6% -$29.1K 0.1% 107
2022
Q1 		$487K Sell
8,948
-800
-8% -$43.5K 0.1% 122
2021
Q4 		$537K Buy
9,748
+920
+10% +$47.9K 0.09% 126
2021
Q3 		$422K Hold
8,828
– – 0.09% 127
2021
Q2 		$439K Hold
8,828
– – 0.1% 113
2021
Q1 		$394K Hold
8,828
– – 0.09% 112
2020
Q4 		$406K Hold
8,828
– – 0.11% 104
2020
Q3 		$415K Hold
8,828
– – 0.13% 90
2020
Q2 		$450K Hold
8,828
– – 0.14% 88
2020
Q1 		$418K Buy
8,828
+280
+3% +$14.9K 0.13% 84
2019
Q4 		$502K Hold
8,548
– – 0.13% 90
2019
Q3 		$456K Sell
8,548
-8,064
-49% -$415K 0.13% 91
2019
Q2 		$831K Hold
16,612
– – 0.24% 75
2019
Q1 		$868K Sell
16,612
-1,120
-6% -$56K 0.26% 74
2018
Q4 		$847K Sell
17,732
-5
-0% -$246 0.23% 74
2018
Q3 		$891K Sell
17,737
-4,385
-20% -$223K 0.23% 79
2018
Q2 		$1.11M Sell
22,122
-2,560
-10% -$129K 0.23% 79
2018
Q1 		$1.21M Buy
24,682
+2,732
+12% +$127K 0.25% 75
2017
Q4 		$974K Buy
21,950
+8,508
+63% +$393K 0.21% 85
2017
Q3 		$682K Sell
13,442
-53
-0.4% -$2.69K 0.15% 96
2017
Q2 		$727K Buy
13,495
+4,800
+55% +$256K 0.16% 98
2017
Q1 		$458K Buy
8,695
+4,458
+105% +$226K 0.09% 117
2016
Q4 		$204K Hold
4,237
– – 0.04% 136
2016
Q3 		$228K Buy
+4,237
New +$232K 0.05% 129
2016
Q2 		– Sell
-4,237
Closed -$215K – 134
2016
Q1 		$215K Sell
4,237
-1,720
-29% -$85.7K 0.06% 127
2015
Q4 		$300K Buy
5,957
+1,440
+32% +$73.4K 0.09% 118
2015
Q3 		$217K Buy
+4,517
New +$235K 0.08% 116

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

GFS Advisors's GSK Position: Q3 2022 in Review

GFS Advisors sold out of GSK (GSK) in Q3 2022, closing a stake of 8,420 shares — an estimated $458K sold.

GFS Advisors first reported a position in GSK in Q3 2015 and held it in 27 quarters. The position peaked at $1.21M in Q1 2018. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • GFS Advisors reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • GFS Advisors sold 8,420 GSK shares in Q3 2022, an estimated $458K.
  • GFS Advisors first reported a position in GSK in Q3 2015 and held it in 27 quarters.
  • GFS Advisors's GSK position peaked at $1.21M in Q1 2018.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on GFS Advisors's 13F filing for Q3 2022, filed 13 Oct 2022.